OCLG — Oncologix Tech Cashflow Statement

0.000.00%

Last trade - 00:00

FinancialsHighly SpeculativeMicro Cap

Annual cashflow statement for Oncologix Tech, fiscal year end - August 31st, USD millions except per share, conversion factor applied.

	2010 August 31st	2011 August 31st	2012 August 31st	2013 August 31st	2014 August 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-0.743	-0.236	-0.286	-0.653	-1.31
Depreciation
Non-Cash Items	0.568	0.007	0.128	0.156	0.812
Discontinued Operations
Unusual Items
Other Non-Cash Items
Changes in Working Capital	-0.051	0.049	0.037	0.639	-0.153
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Other Operating Cash Flow
Cash from Operating Activities	-0.225	-0.179	-0.119	0.147	-0.63
Capital Expenditures	-0.001	0	-0.002	0	-0.001
Purchase of Fixed Assets
Other Investing Cash Flow Items	0	0	—	-0.324	-0.066
Acquisition of Business
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-0	0	-0.002	-0.324	-0.067
Financing Cash Flow Items	0.007	0	—	—	—
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	0.236	0.179	0.112	0.215	0.675
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	0.01	0	-0.009	0.038	-0.022